Last reviewed · How we verify
NCT07113639
Effectiveness of High-Volume Corticosteroid Injection in Shoulder Impingement
NA trial testing Injection in Shoulder Impingement Syndrome in 70 participants. Completed in 1 December 2021.
1 December 2021
Quick facts
| Lead sponsor | TC Erciyes University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 October 2020 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Injection
- Injection
Conditions studied
- Shoulder Impingement Syndrome — all drugs for Shoulder Impingement Syndrome →
Sponsor
TC Erciyes University
Who can join
18 and older, any sex, with Shoulder Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to compare the effectiveness of high-volume versus low-volume ultrasound-guided corticosteroid injections diluted with saline in patients with subacromial impingement syndrome, finding no significant difference in pain or functional outcomes between the two methods.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07113639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Injection
Trials testing the same drug.
- NCT07509164 — The Effect of a Multimodal Approach on Pain, Fear, and Anxiety in Injection Experiences in Children · NA · completed
- NCT07010900 — Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's · NA · recruiting
- NCT06729840 — Intralesional Treatment of Keloids · Phase 3 · recruiting
- NCT06653244 — Morphine, Midazolam and Dexmedetomidine in the Management of Acute Cardiogenic Pulmonary Edema, Safety and Efficacy · Phase 1 · completed
- NCT06093815 — Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products · NA · completed
Other recruiting trials for Shoulder Impingement Syndrome
Currently open trials in the same condition.
- NCT07521839 — Title of This Study is to Evaluate the Effects of Abdominal Drawing in Maneuver With Cross Pattern Limb Exercises in Pat · NA · active not recruiting
- NCT07290660 — Graded Motor Imagery and Task-Oriented Exercise in Shoulder Impingement · NA · recruiting
- NCT07228936 — The Role of Pectoralis Minor Tightness in the Development of Rotator Cuff Tears · recruiting
- NCT06732570 — Effect of High Intensity Laser on Shoulder Impingement. · NA · active not recruiting
- NCT06407804 — Effects of Thrower's Ten and Routine Physical Therapy in Patients With Shoulder Impingement Syndrome · NA · recruiting
Other TC Erciyes University trials
Trials by the same sponsor.
- NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
- NCT07529964 — MMP-2/3 and Periapical Healing Outcomes · not yet recruiting
- NCT07526831 — Comparison of the Analgesic Efficacy of Adductor Canal Block and Combined Adductor Canal Block Plus IPACK Block in Knee · recruiting
- NCT07371806 — EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE · NA · not yet recruiting
- NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07113639 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TC Erciyes University
- Last refreshed: 14 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07113639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing